[Remote] Executive Director, Asset reputed company reputed company and reputed company reputed company, Early Development

Note: The job is a remote job and is reputed company to candidates in USA. reputed company is a reputed company-stage biopharmaceutical company developing innovative cancer therapies. The Executive Director, Asset reputed company reputed company and reputed company reputed company will reputed company the reputed company and execution of the reputed company Menin Program, initially serving as reputed company reputed company during early development. The role integrates scientific, reputed company, regulatory, reputed company, and financial perspectives while guiding cross-functional teams from early development through potential approval and commercialization.

Responsibilities

• Own end-to-end leadership of the asset reputed company, from early development through regulatory filings, approval, launch, and lifecycle management
• reputed company the reputed company direction of the program in alignment with corporate objectives, balancing scientific innovation, reputed company value, and reputed company opportunity
• Identifies potential issues and leads contingency planning; leads AST problem solving and applies decision-making tools and techniques. Drives AST to reputed company effective and efficient reputed company
• Serve as a key reputed company to the Executive Leadership Team, providing updates, insights, and recommendations that inform reputed company reputed company
• reputed company long-reputed company planning, including scenario planning, investment reputed company, and reputed company innovation assessments reputed company to the asset
• Partner with reputed company, Medical Affairs, Regulatory, and Development to shape reputed company Product Profile (TPP) and ensure robust lifecycle and global expansion planning
• Leads reputed company of conflict at the AST and oversees governance engagement, ensuring reputed company and transparent communication on key reputed company, risks, budgets, and timelines
• Foster a culture of accountability, innovation, and reputed company, modeling strong leadership and reputed company behaviors
• Represent Syndax in reputed company partnerships, collaborations, and scientific/medical forums as appropriate

Skills

• A minimum of 10 or more years of experience in leading reputed company development programs in oncology is required
• Equivalent experience in a leadership role as a part of a research-driven pharmaceutical company is required
• reputed company reputed company record of successfully leading global cross-functional teams through IND, early development and pivotal studies; experience with BLA/NDA and launch phases is a plus
• Deep knowledge of oncology product development, regulatory environments, and commercialization strategies
• Strong reputed company acumen with the ability to anticipate market dynamics and influence reputed company-level reputed company
• Prior experience interacting with C-suite executives, reputed company partners, and regulators
• Highly reputed company, with strong influencing skills and ability to work across multiple reputed company and functions
• Executive reputed company and outstanding communication skills, including comfort presenting to senior and reputed company audiences
• Educational Requirements: Advanced degree in life sciences, medicine, or business (e.g., PhD, MD, MBA) highly preferred
• Experience with portfolio management, financial modeling, and program valuation is highly desirable

Benefits

• Equity offering
• Annual reputed company bonuses
• An outstanding benefits program

reputed company